CARDIAC TOXICITY
Clinical trials for CARDIAC TOXICITY explained in plain language.
Never miss a new study
Get alerted when new CARDIAC TOXICITY trials appear
Sign up with your email to follow new studies for CARDIAC TOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart-Saving statins may keep breast cancer treatment on track
Disease control Recruiting nowThis study tests whether taking statins can prevent heart problems caused by HER2-targeted therapy in women with early-stage breast cancer. About 60 participants will receive statins alongside their cancer treatment to see if it reduces treatment delays or early stops due to hear…
Matched conditions: CARDIAC TOXICITY
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated May 07, 2026 18:43 UTC
-
Cancer survivors may finally ditch heart pills – landmark trial begins
Disease control Recruiting nowThis study looks at whether cancer survivors who had heart damage from their cancer treatment, but whose heart function has since recovered, can safely stop taking heart failure medications. About 335 adults who finished cancer therapy at least 6 months ago and are currently on h…
Matched conditions: CARDIAC TOXICITY
Phase: PHASE4 • Sponsor: Dinesh Thavendiranathan • Aim: Disease control
Last updated May 06, 2026 16:14 UTC